• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
Dx Deal Roundup: Key Acquisitions for Danaher & Exact, and a Big AI Partnership

Dx Deal Roundup: Key Acquisitions for Danaher & Exact, and a Big AI Partnership

by Glenn S. Demby | Sep 27, 2023 | Deals-lir, Essential, Lab Compliance Advisor, Laboratory Industry Report, National Lab Reporter

Here are what G2 Intelligence considers the three most significant deals announced in the period from late August to early September.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here

Labs Partner with Pharma Companies to Develop New CDx Tests

by Glenn S. Demby | Jan 31, 2023 | Deals-lir, Essential, Laboratory Industry Report

There were three notable CDx alliances announced in January 2023, all of which involved cancer-related solutions.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Quest and Color Health Join CDC to Promote Equitable COVID-19 Testing

Quest and Color Health Join CDC to Promote Equitable COVID-19 Testing

by Glenn S. Demby | Jul 29, 2022 | Deals-lir, Essential, Laboratory Industry Report

In July, ICATT took a major step toward equitable access to testing by enlisting two of the country’s leading COVID-19 PCR test providers.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Partnership to Create New Tool for Rapid SARS-CoV-2 Variant Detection

Partnership to Create New Tool for Rapid SARS-CoV-2 Variant Detection

by Glenn S. Demby | Mar 31, 2022 | Articles, Deals-lir, Essential, Laboratory Industry Report

Thermo Fisher, Helix, and Rosalind collaborate on an NIH-supported project to develop a new genotyping method to ID virus variants faster.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Amazon Already Making a Mark on Direct-to-Consumer COVID-19 Test Market

Amazon Already Making a Mark on Direct-to-Consumer COVID-19 Test Market

by Glenn S. Demby | Jul 11, 2021 | Articles, Deals-lir, Essential, Laboratory Industry Report

...

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here

Sign up for our free weekly Lab & Pathology Insider email newsletter

Log In

Join Now | Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2025 G2Intelligence.com